Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-07-18

Clinical Trial Update: Study of Olanzapine vs. Aripiprazole in the Treatment of Schizophrenia [Phase 4]

View source ↗

Summary

This Phase 4 trial compares olanzapine with aripiprazole for schizophrenia and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ARIPIPRAZOLE (Aripiprazole)
  • olanzapine (olanzapine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED